期刊文献+

早发性卵巢功能不全患者治疗研究进展 被引量:2

Research Progress in the Treatment of Early-Onset Ovarian Insufficiency
原文传递
导出
摘要 早发性卵巢功能不全(premature ovarian insufficiency,POI)是指女性在40岁之前出现的卵巢功能下降,随着社会经济的迅猛发展,发病率逐年上升,对女性生育能力及老年生活质量带来极大影响,本文主要对POI的治疗研究进展做一综述,为POI女性选择治疗方案提供参考。 Premature ovarian insufficiency(POI)refers to the decline of ovarian function in women before the age of 40.With the rapid development of society and economy,the incidence rate is increasing year by year,which is harmful to women’s fertility and quality of life in the elderly.With great influence,this article mainly reviews the research progress of POI treatment,and provides a reference for women with POI to choose treatment options.
作者 王荣慧 白云 WANG Ronghui;BAI Yun(Shanxi Medical University,Taiyuan 030001,China;Department of Obstetrics and Gynecology Health,Maternity and Child Health Hospital of Shanxi Province/Shanxi Province Children's Hospital General Outpatient,Taiyuan 030001,China)
出处 《实用心脑肺血管病杂志》 2021年第S01期27-30,共4页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 早发性卵巢功能不全 治疗 综述 Primary ovarian insufficiency Treatment Review
  • 相关文献

参考文献6

二级参考文献37

  • 1付莉,赵怡璇,李守柔.卵巢早衰实验动物模型的建立[J].生殖医学杂志,2006,15(3):179-183. 被引量:46
  • 2Wang Wei, Li Jijun. Progression of the study of the etiology of premature ovary failure [ J ]. Progress in Obstetrics and Gynecology,2002, 11 (2) :136-137.
  • 3Tung K, Agersborg S, Bagavant H, et al. Autoimmune ovarian disease induced by immunization with zona pellucida (ZP3) peptide [ J]. Curr Protoc Immunol, 2002, 15: 15-17.
  • 4Burnstein K I, Cidlowski J A. The down side of glueocorticoid receptor[ J ] . Mol Cell Endocrinol, 1992,83 ( 1 ) : 1-8.
  • 5Cowchock F S, McCabe J L, Montgomery B B. Pregnancy after corticosteroid administration in premature ovarian failure ( polyglandular endocrinopathy syndrome ) [ J ] . Am J Obstet Gynecol,1988,158(1) :118-119.
  • 6Korczowska I, Lacki J K, Leszczynski P, et al. Bone tissue metabolism in systematic lupus erythematosus patients treated with glucocorticoids [ J ]. Pol Arch Med Wewn, 2001 ,106(14) :901 -907.
  • 7Jacobson D L, Grange S J, Rose N R, et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States [ J ]. Clin Immunol Immunopathol, 1997 , 84 ( 3 ) :223-243.
  • 8Loria R M. Immune up-regulation and tumor apoptosis by androstene steroids [J]. Steroids,2002,67(12) :953- 966.
  • 9Yano T, Pinski J, Radulovic S, et al. Inhibition of human epithelial ovarian cancer cell growth in vitro by agonistic and antagonistic analogues of luteinizing hormone-releasing hormone [J ]. Proc Natl Acad Sei U S A, 1994, 91 (5) : 1701-1705.
  • 10Asbury RF, Brunetto VL, Lee RB, et al. Goserelin acetate as treat- ment tor recurrent endometrial carcinoma [J]. Am J Clin Oncol, 2002, 25(6): 557-560.

共引文献463

同被引文献29

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部